Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for protection of ovarian reserve and function after chemotherapy in ovarian cancer survivors
ChiCTR1900023486Phase 4Recruiting
- Sponsor
- Tongji Hospital
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of metformin in ovarian injury and primary ovarian insufficiency (POI) (2 arms), sponsored by Tongji Hospital. Primary endpoint: Menstruation recovery rate. Started Oct 2019; status: recruiting.
02
Drugs
metformin
03
Conditions
ovarian injuryprimary ovarian insufficiency (POI)
Beyond the preview
Go deeper on ChiCTR1900023486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023486.